105 related articles for article (PubMed ID: 15248904)
1. [Indomethacin induces apoptosis through inhibition of survivin regulated by beta-catenin/TCF4 in human colorectal cancer cells].
Zhu HX; Zhang G; Wang YH; Zhou CQ; Bai JF; Xu NZ
Ai Zheng; 2004 Jul; 23(7):737-41. PubMed ID: 15248904
[TBL] [Abstract][Full Text] [Related]
2. The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.
Dihlmann S; Siermann A; von Knebel Doeberitz M
Oncogene; 2001 Feb; 20(5):645-53. PubMed ID: 11313997
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells.
Hawcroft G; D'Amico M; Albanese C; Markham AF; Pestell RG; Hull MA
Carcinogenesis; 2002 Jan; 23(1):107-14. PubMed ID: 11756231
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
6. Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin.
Dihlmann S; Klein S; Doeberitz Mv Mv
Mol Cancer Ther; 2003 Jun; 2(6):509-16. PubMed ID: 12813129
[TBL] [Abstract][Full Text] [Related]
7. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.
Ma H; Nguyen C; Lee KS; Kahn M
Oncogene; 2005 May; 24(22):3619-31. PubMed ID: 15782138
[TBL] [Abstract][Full Text] [Related]
8. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
9. [Indomethacin-induced HL-60 cell apoptosis is associated with inhibition of beta-catenin/c-myc signal transduction pathway].
Zhang GS; Wang ZY
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):629-31. PubMed ID: 14761609
[TBL] [Abstract][Full Text] [Related]
10. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
11. The cohesin SMC3 is a target the for beta-catenin/TCF4 transactivation pathway.
Ghiselli G; Coffee N; Munnery CE; Koratkar R; Siracusa LD
J Biol Chem; 2003 May; 278(22):20259-67. PubMed ID: 12651860
[TBL] [Abstract][Full Text] [Related]
12. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
[TBL] [Abstract][Full Text] [Related]
13. Survivin and molecular pathogenesis of colorectal cancer.
Kim PJ; Plescia J; Clevers H; Fearon ER; Altieri DC
Lancet; 2003 Jul; 362(9379):205-9. PubMed ID: 12885482
[TBL] [Abstract][Full Text] [Related]
14. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cells.
Pierce M; Wang C; Stump M; Kamb A
Int J Cancer; 2003 Nov; 107(2):229-37. PubMed ID: 12949799
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
[TBL] [Abstract][Full Text] [Related]
18. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Lab Invest; 2005 Jun; 85(6):768-79. PubMed ID: 15806138
[TBL] [Abstract][Full Text] [Related]
20. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]